Clinical Trial Update: Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated the efficacy and treatment-related toxicity of a new regimen for lymphoma, including Non-Hodgkin's Lymphoma and Hodgkin's Dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Disease
• Non-hodgkin Lymphoma

Snippet

Sponsor: Bayside Health | Conditions: Non-Hodgkin's Lymphoma, Hodgkin's Disease | Phase 2 | Status: COMPLETED